Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Behav Brain Res ; 205(1): 146-53, 2009 Dec 14.
Article in English | MEDLINE | ID: mdl-19539663

ABSTRACT

Transplantation experiments have shown that neurologic deficits may be reversed by engrafting fresh tissue or engineered cells within dysfunctional neural circuitry. In experimental and clinical settings, this approach has provided insights into the pathology and treatment of neurologic diseases, primarily movement disorders. The present experiments were designed to investigate whether a similar strategy is feasible as a method to investigate, and perhaps repair, circuitry integral to emotional disorders. We focused on the amygdala, a macrostructure known to be involved in the expression of anxiety- and fear-related behaviors. GABAergic cell-rich suspensions were prepared from E17 rat lateral ganglionic eminence and engrafted bilaterally into the lateral and basolateral amygdaloid nuclei of young adult rats. After 6 weeks, increased numbers of GABAergic neurons were identified in the vicinity of the graft sites, and electron microscopy provided evidence for functional integration of transplanted cells. Rats with these grafts spent more time in the open arms of the elevated-plus maze, consistent with an anxioloytic-like phenotype. These rats were also less sensitive to the unconditioned anxiogenic effects of light on the acoustic startle response, although fear-potentiated startle was not affected, suggesting that the grafts produced an attenuation of unlearned fear but did not affect acquisition of conditioned fear. Our results raise the possibility that distinct components of emotion can be modulated by strategic neural engraftment.


Subject(s)
Amygdala/surgery , Anxiety Disorders/surgery , Brain Tissue Transplantation , Fetal Tissue Transplantation , Neurons/metabolism , Neurons/transplantation , gamma-Aminobutyric Acid/metabolism , Amygdala/physiopathology , Amygdala/ultrastructure , Animals , Anxiety Disorders/physiopathology , Anxiety Disorders/therapy , Auditory Perception/physiology , Behavior, Animal/physiology , Exploratory Behavior/physiology , Fear/physiology , Male , Maze Learning/physiology , Motor Activity/physiology , Neurons/ultrastructure , Neuropsychological Tests , Rats , Rats, Sprague-Dawley , Reflex, Startle/physiology , Visual Perception/physiology
2.
Brain Res Dev Brain Res ; 157(2): 124-31, 2005 Jun 30.
Article in English | MEDLINE | ID: mdl-15885807

ABSTRACT

The development of the serotonergic (5HT) and dopaminergic (DA) systems may contribute to the onset of psychotic disorders during late adolescence and early adulthood. Previous studies in our laboratory have suggested that these systems may compete for functional territory on neurons during development, as lesions of the serotonergic system at postnatal day 5 (P5) result in an increase in the density of dopaminergic fibers in rat medial prefrontal cortex (mPFC). In the present study, the dopaminergic system of P5 rats was lesioned with intracisternal injections of 6-hydroxydopamine (6-OHDA). Quantification of serotonin-immunoreactivity (5HT-IR) in mPFC at adulthood (P70) revealed a significant decrease in fiber density within layers II and III of the Cg3 subdivision of mPFC in lesioned rats compared to sham controls. We propose that the decrease in serotonergic fibers in mPFC in response to a neonatal depletion of dopamine may be due to the loss of a trophic effect of this system on 5HT neurons and/or fibers during development. Taken together with previous findings, our data suggest that there may be an "inverse trophic" relationship between the cortical DA and 5HT systems whereby dopamine facilitates the ingrowth of 5HT fibers, while serotonin suppresses the ingrowth of DA fibers. We present a model based on neurotrophic interactions at the cortical and brainstem levels that could potentially explain these unexpected results.


Subject(s)
Dopamine/metabolism , Nerve Growth Factors/metabolism , Neural Pathways/metabolism , Prefrontal Cortex/metabolism , Raphe Nuclei/metabolism , Serotonin/metabolism , Animals , Animals, Newborn , Cell Communication/physiology , Cell Differentiation/physiology , Denervation , Disease Models, Animal , Down-Regulation/physiology , Growth Cones/metabolism , Immunohistochemistry , Male , Mental Disorders/etiology , Mental Disorders/physiopathology , Models, Neurological , Neural Pathways/growth & development , Neural Pathways/physiopathology , Oxidopamine , Prefrontal Cortex/growth & development , Prefrontal Cortex/physiopathology , Raphe Nuclei/growth & development , Raphe Nuclei/physiopathology , Rats , Rats, Sprague-Dawley , Sympatholytics
SELECTION OF CITATIONS
SEARCH DETAIL
...